Sivan Elloul

871 total citations
24 papers, 742 citations indexed

About

Sivan Elloul is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sivan Elloul has authored 24 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Immunology. Recurrent topics in Sivan Elloul's work include Nuclear Structure and Function (11 papers), CAR-T cell therapy research (6 papers) and Cancer Cells and Metastasis (5 papers). Sivan Elloul is often cited by papers focused on Nuclear Structure and Function (11 papers), CAR-T cell therapy research (6 papers) and Cancer Cells and Metastasis (5 papers). Sivan Elloul collaborates with scholars based in United States, Norway and Israel. Sivan Elloul's co-authors include Ben Davidson, Reuven Reich, Claes G. Tropé, Iris Goldberg, Jahn M. Nesland, Claes G. Tropé, Ilvars Silins, Avi Benshushan, Helene Tuft Stavnes and Olga Vaksman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sivan Elloul

23 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sivan Elloul United States	9	511	375	151	92	71	24	742
Swati Jalgaonkar United States	5	490 1.0×	458 1.2×	236 1.6×	82 0.9×	83 1.2×	7	782
Silvana Di Giandomenico United States	10	537 1.1×	263 0.7×	184 1.2×	115 1.3×	52 0.7×	16	865
Prasad Chaskar Switzerland	6	372 0.7×	387 1.0×	187 1.2×	63 0.7×	56 0.8×	8	600
Jason P.W. Carey United States	12	386 0.8×	307 0.8×	101 0.7×	111 1.2×	51 0.7×	13	582
Helene Tuft Stavnes Norway	16	364 0.7×	168 0.4×	250 1.7×	93 1.0×	48 0.7×	19	622
Rinat Keren United States	5	532 1.0×	327 0.9×	160 1.1×	63 0.7×	141 2.0×	5	763
Kaltin Ferguson Australia	13	276 0.5×	229 0.6×	168 1.1×	71 0.8×	31 0.4×	21	559
Laura Romero‐Pérez Spain	13	443 0.9×	163 0.4×	292 1.9×	117 1.3×	117 1.6×	14	710
E‐Jean Tan Sweden	11	597 1.2×	293 0.8×	269 1.8×	76 0.8×	83 1.2×	13	809
Shun‐Dong Dai China	21	640 1.3×	235 0.6×	143 0.9×	184 2.0×	102 1.4×	47	917

Countries citing papers authored by Sivan Elloul

Since Specialization

Citations

This map shows the geographic impact of Sivan Elloul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivan Elloul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivan Elloul more than expected).

Fields of papers citing papers by Sivan Elloul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivan Elloul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivan Elloul. The network helps show where Sivan Elloul may publish in the future.

Co-authorship network of co-authors of Sivan Elloul

This figure shows the co-authorship network connecting the top 25 collaborators of Sivan Elloul. A scholar is included among the top collaborators of Sivan Elloul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivan Elloul. Sivan Elloul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spira, Alexander I., et al.. (2022). A phase 1/2 study of RTX-224, an engineered red blood cell expressing 4-1BB ligand and membrane-bound IL-12, for the treatment of patients with select advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). TPS2680–TPS2680. 1 indexed citations

McArdel, Shannon, Anne‐Sophie Dugast, Enping Hong, et al.. (2021). Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15. Cancer Immunology Immunotherapy. 70(9). 2701–2719. 15 indexed citations

Dugast, Anne‐Sophie, Shannon McArdel, Zafira Castaño, et al.. (2021). 208 RTX-224, an engineered allogeneic red cell therapeutic expressing 4–1BBL and IL-12, activates immune cells in blood and spleen to promote tumor growth inhibition in mice. SHILAP Revista de lepidopterología. A219–A219. 2 indexed citations

Dugast, Anne‐Sophie, Shannon McArdel, Enping Hong, et al.. (2020). 144 RTX-240, an allogeneic engineered red blood cell expressing 4–1BBL and IL-15TP, promotes NK cell functionality in vitro and in vivo. SHILAP Revista de lepidopterología. A87.1–A87. 1 indexed citations

Farren, Matthew R., Reena Shakya, Gregory Young, et al.. (2017). The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. Molecular Cancer Therapeutics. 16(3). 417–427. 23 indexed citations

Muqbil, Irfana, Amro Aboukameel, Sivan Elloul, et al.. (2016). Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone. Cancer Letters. 383(2). 309–317. 31 indexed citations

Elloul, Sivan, et al.. (2016). Engineered Erythrocytes As an Anti-Tumor Therapy through Induction of Apoptosis or Immune-Checkpoint Inhibition. Blood. 128(22). 2166–2166. 2 indexed citations

Argueta, Christian, Hua Chang, Trinayan Kashyap, et al.. (2016). Synergistic Anti-Tumor Effect of KPT-8602, a Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, and Panobinostat, a Pan-Histone Deacetylase (HDAC) Inhibitor in Multiple Myeloma. Blood. 128(22). 3298–3298. 7 indexed citations

Elloul, Sivan, Hua Chang, Boris Klebanov, et al.. (2016). Abstract 1299: Selinexor, a selective inhibitor of nuclear export (SINE) compound shows enhanced anti-tumor activity when combined with either venetoclax or bendamustine in diffuse large B cell lymphoma (DLBCL) mouse models. Cancer Research. 76(14_Supplement). 1299–1299. 2 indexed citations

10.

Elloul, Sivan, Hua Chang, Boris Klebanov, et al.. (2016). Abstract 2219: Selinexor, a selective inhibitor of nuclear export (SINE) compound, shows synergistic anti-tumor activity when combined with PD-1 blockade in a mouse model of colon cancer. Cancer Research. 76(14_Supplement). 2219–2219. 3 indexed citations

11.

Gery, Sigal, Sivan Elloul, Sharon Friedlander, et al.. (2015). Abstract LB-255: Selinexor, a selective inhibitor of nuclear export (SINE) compound, shows enhanced antitumor activity in combination with the PARP inhibitor, olaparib, in models of triple-negative breast cancer. Cancer Research. 75(15_Supplement). LB–255. 2 indexed citations

12.

Rashal, Tami, Sivan Elloul, Marsha Crochiere, et al.. (2015). Abstract 4490: Selinexor (KPT-330) radio-sensitizes non-small cell lung cancer cells in vitro and in vivo. Cancer Research. 75(15_Supplement). 4490–4490. 1 indexed citations

13.

Farren, Matthew R., Reena Shakya, Thomas A. Mace, et al.. (2015). Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations

14.

Azmi, Asfar S., Amro Aboukameel, Robert Carlson, et al.. (2015). Abstract 1756: Preclinical activity in non-Hodgkin's lymphoma of Selinexor, a selective inhibitor of nuclear export (SINE), is enhanced through combination with standard-of-care therapies. Cancer Research. 75(15_Supplement). 1756–1756. 1 indexed citations

15.

Elloul, Sivan, Dmitriy Kedrin, Nicholas Knoblauch, Andrew H. Beck, & Alex Toker. (2013). The Adherens Junction Protein Afadin Is an AKT Substrate that Regulates Breast Cancer Cell Migration. Molecular Cancer Research. 12(3). 464–476. 40 indexed citations

16.

Elloul, Sivan, Olga Vaksman, Helene Tuft Stavnes, et al.. (2010). Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions. Clinical & Experimental Metastasis. 27(3). 161–172. 65 indexed citations

17.

Elstrand, Mari Bunkholt, Hiep Phuc Dong, Arild Holth, et al.. (2010). Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma. Human Pathology. 41(6). 794–804. 42 indexed citations

18.

Hadar, Rivka, et al.. (2006). Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer. 54(3). 309–317. 37 indexed citations

19.

Elloul, Sivan, Ilvars Silins, Claes G. Tropé, et al.. (2006). Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(5). 520–528. 93 indexed citations

20.

Elloul, Sivan, Jahn M. Nesland, Claes G. Tropé, et al.. (2005). Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 103(8). 1631–1643. 364 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact